[We chose PX-866 as a PI3K inhibitor as it is a clinically promising agent being evaluated for brain tumor therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
Gene-disease associations inferred from text-mining the literature.
DisGeNET evidence - LITERATURE